Pentavalent vaccine

BIOLOGICAL2 trials

Sponsors

GlaxoSmithKline, International Centre for Diarrhoeal Disease Research, Bangladesh

Conditions

PolioSalmonella Infections

Phase 2

A Study on the Safety, Reactogenicity, and Immune Response to the GVGH iNTS-GMMA Vaccine Against Invasive Nontyphoidal Salmonella in Adults, Children, and Infants

RecruitingNCT06213506

GlaxoSmithKlineSalmonella Infections

Start: 2024-01-15End: 2026-04-27Target: 516Updated: 2024-01-19

Phase 4

Immunogenicity of Different Primary Immunization Schedules with Inactivated Poliovirus Vaccine (IPV) Plus Pentavalent Vaccine (DTwP-HBV-Hib) or with Hexavalent Vaccine (DTwP-HBV-Hib-IPV)

Not yet recruitingNCT06748612

International Centre for Diarrhoeal Disease Research, BangladeshPolio

Start: 2025-01-28End: 2027-12-30Target: 1190Updated: 2024-12-27